Arena (ARNA) Snubs Downgrade, Now Higher on the Session
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
Arena Pharmaceuticals (Nasdaq: ARNA) shares are moving higher as sentiment returns to the pharma ahead of its PDUFA for lorcaserin.
After starting a couple of percentage points lower Monday on a downgrade at BMO Capital, shares are now about 1.5 percent higher.
Volatility is modest, up from 1 percent to 3 percent from last Friday's close and about at par with its trailing historical measure. Volume is solid on the move as well, with about 8 million shares traded early.
After starting a couple of percentage points lower Monday on a downgrade at BMO Capital, shares are now about 1.5 percent higher.
Volatility is modest, up from 1 percent to 3 percent from last Friday's close and about at par with its trailing historical measure. Volume is solid on the move as well, with about 8 million shares traded early.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Upgrades Robert Half (RHI) to Outperform
- Lucid Group stock surges 24% on Saudi prince investment
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
